Needham: Reiterated the Esperion Therapeutics (ESPR.US) rating, adjusted from buy to buy rating, target price $8.00.
Needham：重申Esperion Therapeutics(ESPR.US)评级，由买入调整至买入评级, 目标价8.00美元。
Needham: Reiterated the Esperion Therapeutics (ESPR.US) rating, adjusted from buy to buy rating, target price $8.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.